Kanabo Group Plc announced the appointment of Sharon Malka as Non-Executive Director (NED) with immediate effect. The company also announced that Gil Efron will step down from his position as a Non-Executive Director with immediate effect, in order to focus on his rehabilitation following a recent accident. Sharon Malkawill assume the role of Chair of the Audit Committee following Gil's departure.

Sharon Malka brings a wealth of experience to Kanabo, having held senior leadership positions with a number of international healthcare and technology companies. Sharon Malka is currently Chief Executive Officer of Dotz Nano Ltd. In addition to his position at Dotz, Sharon Malka has spent the past 16 years at MediWound Limited. Sharon is a member of MediWound Limited's Board of Directors, and he has previously been MediWound Limited's Chief Financial Officer and Chief Executive Officer.

Previously, Sharon held the role of Partner at Variance Economic Consulting Ltd. and served as a Senior Manager position for PwC Corporate Finance. Sharon Malka is a qualified accountant and holds a B.Sc. in Business Administration from the Business Management College in Israel and an M.B.A. from Bar Ilan University, Israel.